Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)

• Status: Completed
• Trial end date: 2017-08-01
• Target enrollment: 0
• Participant gender: Male

Summary

This study will investigate the efficacy and safety of fedovapagon in the treatment of nocturia in men with BPH.

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Vantia Ltd

Criteria

Inclusion Criteria:

• Adult males ≥18 years [no upper limit]

• Benign prostatic hyperplasia

• Persistent nocturia despite previous lifestyle modification advice including appropriate fluid management

• Serum sodium not below lower limit of normal prior to randomization

• Provide signed and dated informed consent before any study-specific procedures are conducted.

• Able to comply with the requirements of the study.

Exclusion Criteria:

-